Licensing strategies have gained much attention among practitioners. However, academic
research on the topic is, compared to similar domains such as franchising, more limited and …

Interdisciplinary research (IDR) has raised increasing expectations among scholars and
policymakers about its potential to produce ground-breaking scientific contributions and …

Although it is well recognized that human capital is an important strategic asset for firms, the
evidence regarding its role in developing new products is inconclusive. Prior research has …

Pharmaceutical firms frequently engage in preclinical research collaboration with
universities. Many of these collaborative preclinical research projects are conducted by …

Abstract Research Summary Strategy scholars view innovation through the lens of
knowledge recombination, whereas organizational economics scholars view innovation …

Although the relationship between competition and firm innovation has long been of
scholarly interest, prior research has predominantly considered changes in internal research …

The ability to access specialized complementary assets has been key to explaining how
firms benefit from their technological innovations. When firms lack complementary assets the …

We develop a novel framework to explain how the unique properties of out‐licensing enable
R&D reconfiguration in the context of technology acquisitions. Out‐licensing is an attractive …

Our research examines the effect of the compositional quality of firms' direct and indirect
network ties on their innovation performance in a licensing context. It addresses the …

Interorganizational partnerships can spur innovation, but their value may be diminished by
friction in knowledge flows between firms. We consider how a partner's organizational …